Showing 491-500 of 7110 results for "".
Crisis Management: Office Operations, Part 1
https://practicaldermatology.com/topics/practice-management/crisis-management-office-operations-part-1/18181/How are primarily cosmetic dermatology practices dealing with shutdowns and preparing for the future? Host Neal Bhatia, MD discusses with Deirdre Hooper, MD, Ashish Bhatia, MD, Kevin Pinski, MD, and Nancy Samolitis, MD.Building A Practice’s Value: Establishing the Model
https://practicaldermatology.com/topics/practice-management/building-a-practices-value-establishing-the-model/23098/There are multiple opportunities for dermatology practices to potentially add value, but there is no one-size-fits-all formula.Event Marketing: Strategies to Spotlight Your Practice and Cosmetic Services
https://practicaldermatology.com/topics/practice-management/event-marketing-strategies-to-spotlight-your-practice-and-cosmetic-services/20335/The notion of hosting an event can be overwhelming, but many practices find the endeavor worthwhile. Ahead are tips for success—and a word of caution.It's Not Raining Men: The Reality of Male Aesthetics
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/its-not-raining-men-the-reality-of-male-aesthetics/20337/Before you adjust your brand to attract more men, a student of human behavior pontificates on the paucity of male cosmetic patients.Spirit Squad: How to Fix Broken Morale
https://practicaldermatology.com/topics/practice-management/spirit-squad-how-to-fix-broken-morale/20479/Manage low morale effectively before it hurts your practice.Biosimilars: Generic Biologics or Something Much More Complex?
https://practicaldermatology.com/topics/practice-management/biosimilars-generic-biologics-or-something-much-more-complex/21013/The looming availability of biosimilar medications raises important clinical and regulatory questions.Inside Cosmeceutical Marketing Claims
https://practicaldermatology.com/topics/general-topics/inside-cosmeceutical-marketing-claims/21642/Dermatologists and their patients may wonder what makes a product “dermatologist tested” or “clinically proven.” Here's what you need to know.Are We Overlooking Skin Cancer in Ethnic Minorities?
https://practicaldermatology.com/issues/supplements/are-we-overlooking-skin-cancer-in-ethnic-minorities/21718/Skin cancers in Hispanic and African American patients may be detected at more advanced stages, leading to poorer prognoses and long-term outcomes compared to non-Hispanic whites.A Highly Effective Topical Compounded Medication for the Treatment of Cutaneous Warts
https://practicaldermatology.com/topics/general-topics/a-highly-effective-topical-compounded-medication-for-the-treatment-of-cutaneous-warts/20583/A compounded formulation with an adhesive vehicle shows promise for one of the most common and frustrating conditions to treat in dermatology.The Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
https://practicaldermatology.com/topics/psoriasis/the-latest-on-systemic-agents-for-psoriasis/29073/The pharmacologic pipeline continues to produce strong options for systemic treatment of psoriasis. Practical Dermatology® spoke with Editorial Board member Jashin J. Wu, MD, FAAD, Founder and CEO of the Dermatology Research and Education Foundation, to discuss the latest treatment considerations wi